The prescribed dosage for Breo Ellipta may depend on your individual treatment plan. Factors like your condition, medical history, age, and other treatments you take may affect your dosage of Breo ...
The Food and Drug Administration (FDA) has approved Breo Ellipta (fluticasone furoate/vilanterol) for the once-daily treatment of asthma in patients aged 18 years and older. The approval of the ...
BREO is a fixed-dose combination of the inhaled corticosteroid fluticasone furoate and the long-acting beta2-agonist (LABA) vilanterol. Two strengths, 100/25mcg and 200/25mcg, have now been approved ...
(AP) A panel of respiratory experts has voted in favor of approving an experimental inhaler drug from GlaxoSmithKline and Theravence for treating chronic lung disease. A majority of Food and Drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback